Purchasers Win Cert. Again In Blood Test Antitrust MDL

Law360, Los Angeles (October 19, 2015, 10:53 PM EDT) -- A Pennsylvania federal judge on Monday recertified a class of buyers of reagents used in blood tests in multidistrict litigation alleging that a former Johnson & Johnson unit conspired with another company to fix prices on the reagents.

U.S. District Judge Jan E. DuBois decided that an expert’s methodologies for calculating classwide damages survived a Daubert analysis because he had reliably estimated the alleged overcharge in a supposed scheme between former J&J unit Ortho-Clinical Diagnostics Inc. — now owned by the Carlyle Group — and Immucor...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.